miR‑302d‑3p regulates the viability, migration and apoptosis of breast cancer cells through regulating the TMBIM6‑mediated ERK signaling pathway

Liao,Yanru; Qiu,Zhenxiong; Bai,Ling

doi:10.3892/mmr.2021.12493

miR‑302d‑3p regulates the viability, migration and apoptosis of breast cancer cells through regulating the TMBIM6‑mediated ERK signaling pathway

Authors:
- Yanru Liao
- Zhenxiong Qiu
- Ling Bai
View Affiliations

Affiliations: Department of Thyroid and Breast Surgery, Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong 518102, P.R. China, Department of General Surgery, Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong 518102, P.R. China, Department of Pathology and Central Laboratory, Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong 518102, P.R. China
Published online on: October 14, 2021 https://doi.org/10.3892/mmr.2021.12493
Article Number: 853
Copyright: © Liao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRs/miRNAs) play important roles in the occurrence, metastasis and prognosis of multiple types of cancers. However, the specific role of miR‑302d‑3p and its underlying mechanism in breast cancer (BC) have not yet been reported. The present study aimed to identify the role of miR‑302D‑3p in BC and its potential mechanism using BC cell lines MCF7 and MDA‑MB‑231 and normal breast epithelial cell MCF‑10A. Cancer and paracancerous tissue from patients with BC were also used. Reverse transcription‑quantitative PCR was performed to detect the expression of miR‑302d‑3p and transmembrane Bax inhibitor motif containing 6 (TMBIM6). Dual‑luciferase reporter assays verified the binding sites of miR‑302d‑3p and TMBIM6. Immunohistochemistry was used to measure the expression of TMBIM6. Cell transfection techniques were used to overexpress or interfere with miR‑302d‑3p and TMBIM6. A Cell Counting Kit‑8 assay was performed to detect cell viability, and migration was measured using a wound healing assay. Apoptosis was detected by flow cytometry. The expression levels of apoptosis‑related proteins and pathway‑related proteins were detected by western blotting. The expression of miR‑302d‑3p in BC cell lines was found to be downregulated. It was also demonstrated that miR‑302d‑3p could inhibit cell viability and migration and promote apoptosis. The expression of TMBIM6 in BC cell lines and tissues was upregulated. Upregulated miR‑302d‑3p was shown to inhibit viability and migration, and promote apoptosis by targeting TMBIM6, during which extracellular signal‑regulated kinase (ERK) and its phosphorylation were inhibited in the ERK signaling pathway in cells. Overall, the present study demonstrated that miR‑302d‑3p could regulate the viability, migration and apoptosis of BC cells through regulating TMBIM6‑mediated ERK signaling pathway.

View Figures

View References

1	Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV and Mitsis M: Breast cancer in young women: An overview. Updates Surg. 69:313–317. 2017. View Article : Google Scholar : PubMed/NCBI
2	Merino Bonilla JA, Torres Tabanera M and Ros Mendoza LH: Breast cancer in the 21st century: From early detection to new therapies. Radiologia. 59:368–379. 2017. View Article : Google Scholar : PubMed/NCBI
3	Tian Z, Tang J, Liao X, Yang Q, Wu Y and Wu G: An immune-related prognostic signature for predicting breast cancer recurrence. Cancer Med. 9:7672–7685. 2020. View Article : Google Scholar : PubMed/NCBI
4	Li Y, Huo J, Pan X, Wang C and Ma X: MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells. Onco Targets Ther. 11:1275–1284. 2018. View Article : Google Scholar : PubMed/NCBI
5	Erratum: MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells [Erratum]. Onco Targets Ther. 11:22032018. View Article : Google Scholar : PubMed/NCBI
6	Ecevit CO, Aktas S, Tosun Yildirim H, Demirağ B, Erbay A, Karaca İ, Çelik A, Demir AB, Erçetin AP and Olgun N: MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d expressions in hepatoblastoma and clinical importance. J Pediatr Hematol Oncol. 41:7–12. 2019. View Article : Google Scholar : PubMed/NCBI
7	Chen D and Yang H: Integrated analysis of differentially expressed genes in breast cancer pathogenesis. Oncol Lett. 9:2560–2566. 2015. View Article : Google Scholar : PubMed/NCBI
8	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
9	Wang S, Zheng Y, Hu Z, Wang Z, Zhang Y and Wei L: Downregulated miR302d3p promotes chondrocyte proliferation and migration by regulation of Unc-51-like kinase 1. Int J Mol Med. 44:1039–1047. 2019.PubMed/NCBI
10	Xu J, Wang Y, Hua X, Xu J, Tian Z, Jin H, Li J, Wu XR and Huang C: Inhibition of PHLPP2/cyclin D1 protein translation contributes to the tumor suppressive effect of NFκB2 (p100). Oncotarget. 7:34112–34130. 2016. View Article : Google Scholar : PubMed/NCBI
11	Wang F, Yang L, Sun J, Zheng J, Shi L, Zhang G and Cui N: Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-κB and FGF2. Mol Biosyst. 13:1345–1354. 2017. View Article : Google Scholar : PubMed/NCBI
12	Ishikawa T, Watanabe N, Nagano M, Kawai-Yamada M and Lam E: Bax inhibitor-1: A highly conserved endoplasmic reticulum-resident cell death suppressor. Cell Death Differ. 18:1271–1278. 2011. View Article : Google Scholar : PubMed/NCBI
13	Xu Q and Reed JC: Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell. 1:337–346. 1998. View Article : Google Scholar : PubMed/NCBI
14	Junjappa RP, Kim HK, Park SY, Bhattarai KR, Kim KW, Soh JW, Kim HR and Chae HJ: Expression of TMBIM6 in cancers: The involvement of Sp1 and PKC. Cancers (Basel). 11:9742019. View Article : Google Scholar : PubMed/NCBI
15	Lee GH, Chae HJ and Kim HR: Monoamine carboxylate transporters are involved in BI-1-associated cancer metastasis in HT1080 colon fibrosarcoma cells. Int J Oncol. 39:209–216. 2011.PubMed/NCBI
16	Li D, Wei Y, Xu S, Niu Q, Zhang M, Li S and Jing M: A systematic review and meta-analysis of bidirectional effect of arsenic on ERK signaling pathway. Mol Med Rep. 17:4422–4432. 2018.PubMed/NCBI
17	Yang C, Yu H, Chen R, Tao K, Jian L, Peng M, Li X, Liu M and Liu S: CXCL1 stimulates migration and invasion in ERnegative breast cancer cells via activation of the ERK/MMP2/9 signaling axis. Int J Oncol. 55:684–696. 2019.PubMed/NCBI
18	Sheng W, Chen C, Dong M, Wang G, Zhou J, Song H, Li Y, Zhang J and Ding S: Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway. Cell Death Dis. 8:e31472017. View Article : Google Scholar : PubMed/NCBI
19	Maehara O, Suda G, Natsuizaka M, Ohnishi S, Komatsu Y, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, et al: Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Carcinogenesis. 38:1073–1083. 2017. View Article : Google Scholar : PubMed/NCBI
20	Buffet C, Hecale-Perlemoine K, Bricaire L, Dumont F, Baudry C, Tissier F, Bertherat J, Cochand-Priollet B, Raffin-Sanson ML, Cormier F and Groussin L: DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers. PLoS One. 12:e01848612017. View Article : Google Scholar : PubMed/NCBI
21	Zhao L, Wang Y, Jiang L, He M, Bai X, Yu L and Wei M: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). J Exp Clin Cancer Res. 35:252016. View Article : Google Scholar : PubMed/NCBI
22	Kim JH, Lee ER, Jeon K, Choi HY, Lim H, Kim SJ, Chae HJ, Park SH, Kim S, Seo YR, et al: Role of BI-1 (TEGT)-mediated ERK1/2 activation in mitochondria-mediated apoptosis and splenomegaly in BI-1 transgenic mice. Biochim Biophys Acta. 1823:876–888. 2012. View Article : Google Scholar : PubMed/NCBI